Skip to main content
1-featuredimage

Welcome to hubXchange's Antibody Therapeutics Xchange Europe 2025.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Target Selection & Mechanisms of Action, Lead Identification & Optimization, Formats & ScaffoldsBi/Multispecifics, & AI & Machine Learning,

Attendees can engage in roundtable discussions, pre-booked 1:1 meetingspresentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate antibody therapeutics.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking.

Europe | Monday 1st December 2025 | 08:00am - 06:50pm

VIEW AGENDA    REGISTER FOR FREE    OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

 

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
08:30
  1. 30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
09:05
  1. Target Selection & Mechanisms of Action
    55 mins
    • Target Selection & Mechanisms of Action
    There is a broad choice of formats and mode of actions for biologics, from simple IgGs to multispecifics, ADCs and CARs The right choice will be essential for clinical success: How to select the best ...
  2. Lead Identification & Optimization
    55 mins
    • Lead Identification & Optimization
    Can AI/ML really help to speed up antibody discovery (already)? How far can we get without a lab? What are the requirements of leads for multispecific formats and ADCs? Are they identical to "naked" a ...
  3. Formats & Scaffolds
    55 mins
    • Formats & Scaffolds
    How can multispecific antibody fragments and scaffolds rival the well-established bispecific Antibody formats in terms of developability and PK? Given the size of the bispecifics development pipeline ...
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
  5. AI & Machine Learning
    60 mins
    • AI & Machine Learning
    Prerequisites/challenges associated with AI-driven de novo discovery of antigen-specific antibodies. Data-pair quantity and quality specifications for training AI-models at all stages, from initial pr ...
10:10
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
10:40
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
11:10
  1. Morning Refreshments
    10 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
11:20
  1. Target Selection & Mechanisms of Action
    60 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    60 mins
    • Lead Identification & Optimization
  3. Formats & Scaffolds
    60 mins
    • Formats & Scaffolds
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
    How do you decide which bispecific format to use for a particular therapeutic goal? To what extent should format decisions be driven by biology of the target versus manufacturability or clinical consi ...

    Veraxa Biotech

  5. AI & Machine Learning
    60 mins
    • AI & Machine Learning
12:20
  1. Networking Lunch
    60 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
13:25
  1. 30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
14:00
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
14:35
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
15:05
  1. Afternoon Refreshments
    10 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization
15:15
  1. Target Selection & Mechanisms of Action
    30 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    30 mins
    • Lead Identification & Optimization
    Therapeutic antibodies—like other biotherapeutic proteins—can trigger unwanted immune responses, impacting both drug efficacy and patient safety. Early assessment of immunogenicity risk is critical to ...

    ImmuneSpec

  3. Formats & Scaffolds
    30 mins
    • Formats & Scaffolds
  4. Bi/Multispecifics
    30 mins
    • Bi/Multispecifics

    Evitria

  5. AI & Machine Learning
    30 mins
    • AI & Machine Learning
15:50
  1. Target Selection and Mechanisms of Action
    60 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    60 mins
    • Lead Identification & Optimization
  3. Formats & Scaffolds
    60 mins
    • Formats & Scaffolds
    Nature of potential  building blocks? How to assembly those building blocks? Which are the parameter to consider? How to create a complex product?
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
  5. AI & Machine Learning
    60 mins
    • AI & Machine Learning
    How does, or will, AI / ML improve antibody engineering? Will it become faster or more precise? How can we metricise that improvement? AI assisted antibody engineering will only be as good as the trai ...
16:50
  1. Drinks-Canape Reception
    60 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • AI & Machine Learning
    • Lead Identification & Optimization

EVENT INFORMATION

3-featuredimage

DATES

Europe
Dec 1, 2025

Monday 1st December 2025

 

DoubleTree by Hilton San Francisco Airport Hotel Photo

VENUE

Hilton Munich Airport Hotel

Terminalstraße Mitte 20
85356 München-Flughafen
Germany

MAP

EVENT PARTNERS

4-featuredimage

EVENT PARTNERS

OUR MEDIA PARTNERS

5-featuredimage

REGISTRATION FORM - Register for free!

6-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.